BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 455570)

  • 1. Evaluation of cardiac activity and pharmacokinetic analysis of 3H-adriamycin in patients pretreated with beta-methyldigoxin.
    Di Fronzo G; Bertuzzi A; Ronchi E; Villani FP; Ronchetti L
    Cancer Chemother Pharmacol; 1979; 2(3):169-73. PubMed ID: 455570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of doxorubicin cardiotoxicity in patients treated intermittently with beta-methyldigoxin.
    Villani F; Comazzi R; Di Fronzo G; Bertuzzi A; Guindani A
    Tumori; 1982 Aug; 68(4):349-53. PubMed ID: 7147362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Serum levels of beta-methyldigoxin and contractile efficiency of the myocardium evaluated with systolic polygraphy and determination of cardiac output].
    Pelosi G; Bracchi G; Orazio S; Cereda A
    Minerva Med; 1981 Feb; 72(4-5):225-31. PubMed ID: 7010220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of action of beta-methyldigoxin and digoxin utilizing systolic time intervals.
    Katdare AD; Namjoshi SA; Nair KG
    J Int Med Res; 1980; 8(1):50-5. PubMed ID: 7358204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic effects and pharmacokinetics of beta-methyldigoxin.
    Cristodorescu R; Gavrilescu S; Deutsch G; Popoviciu V; Comşulea L; Luca C
    Med Interne; 1981; 19(3):265-75. PubMed ID: 7302506
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical study of the interaction between prajmalium bitartrate and beta-methyldigoxin].
    Haasis R; Mikulla A; Roth W
    Med Welt; 1980 Oct; 31(43):1560-2. PubMed ID: 7007790
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cardiac effects of a single daily dose of 0.15 mg and 0.20 mg of beta-methyldigoxin].
    Belz GG; Wintrich R
    Z Kardiol; 1984 Jan; 73(1):29-33. PubMed ID: 6367246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of beta-methyldigoxin on the embryonal and fetal chicken heart].
    Rickenbacher J; Schläpfer R
    Schweiz Med Wochenschr; 1985 May; 115(18):625-9. PubMed ID: 4001908
    [No Abstract]   [Full Text] [Related]  

  • 9. Relationship between myocardial uptake and actions in heart failure of methyldigoxin.
    Hayward R; Greenwood H; Stephens J; Hamer J
    Br J Clin Pharmacol; 1983 Jan; 15(1):41-8. PubMed ID: 6849743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrophysiological effects soon after intravenous beta-methyldigoxin.
    Mahar L; Rowland E; Curry P; Krikler D
    Eur J Cardiol; 1979 Mar; 9(3):241-9. PubMed ID: 421724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Quadratic analysis of left ventricular ejection phase volume using a M-mode echocardiogram, and the effects of beta-methyldigoxin, nifedipine, physical exercise and propranolol on new parameters].
    Suzuki K
    Nihon Ika Daigaku Zasshi; 1988 Dec; 55(6):527-38. PubMed ID: 3209669
    [No Abstract]   [Full Text] [Related]  

  • 12. Interaction between verapamil and beta-methyldigoxin. Study by 86Rubidium uptake in erythrocytes.
    De Cesaris R; Balestrazzi M; Chiarappa R; Ranieri G
    Int J Clin Pharmacol Res; 1983; 3(2):107-9. PubMed ID: 6679512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of digoxin and beta-methyldigoxin on the heart rate of decompensated patients with atrial fibrillation.
    Andersson KE; Johansson BW; Ledermann H; von Schenck H; Thorell JI
    Eur J Clin Invest; 1977 Feb; 7(1):3-6. PubMed ID: 402273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical importance of determining the digoxin level in the serum in long-term beta-methyldigoxin treatment].
    Todorova R; Baltadzhieva D; Staneva D
    Vutr Boles; 1987; 26(6):26-9. PubMed ID: 3439149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of beta-methyldigoxin in healthy humans III: Pharmacodynamic correlations.
    Hinderling PH; Garrett ER
    J Pharm Sci; 1977 Mar; 66(3):326-9. PubMed ID: 851492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacokinetics of beta-methyldigoxin and beta-acetyldigoxin in patients with cirrhosis of the liver (author's transl)].
    Rameis H; Bonelli J; Waginger H; Hruby K
    Wien Klin Wochenschr; 1981 Oct; 93(18):572-6. PubMed ID: 7303703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue distribution and elimination of digoxin and methyldigoxin after single and multiple doses in dogs.
    Kuhlmann J; Rietbrock N; Schnieders B
    J Cardiovasc Pharmacol; 1979; 1(2):219-34. PubMed ID: 94391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative study on the bradycardizing effect of beta-methyl-digoxin and digoxin in chronic auricular fibrillation].
    Pallares C; Richart JA; Bros R; Luque MT; Saenz L; Gausi C
    Rev Esp Cardiol; 1979; 32(1):21-9. PubMed ID: 441482
    [No Abstract]   [Full Text] [Related]  

  • 19. Amplification of serotonin-induced contractions of isolated porcine coronary arteries after pretreatment with therapeutic doses of beta-methyldigoxin.
    Hoang ND; Sick P
    Eur J Pharmacol; 1987 Mar; 135(1):89-91. PubMed ID: 3569427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of daunomycin on myocardial contractility and on the action of beta-methyldigoxin.
    Bossa R; Galatulas I; Spiti R
    Pharmacology; 1980; 21(6):400-2. PubMed ID: 7220592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.